NOTICE TO THE MARKET
CREATION OF VIDA V IN PARTNERSHIP WITH TELADOC HEALTH
Telefônica Brasil S.A. ('Company' or 'Vivo') (B3: VIVT3, NYSE: VIV), in the form and for the purpose of CVM Instruction 358/2002, communicates to its shareholders and the market in general that it has signed a binding memorandum of understanding for the creation of Vida V, in partnership with Teladoc Health ('Teladoc'), world leader in telemedicine.
Vida V is a new digital health and wellness platform that will provide individuals and small and medium-sized companies with access to telemedicine and other correlated solutions.
The service, which is expected to be launched during the coming months, will be available to any consumer, including those who are not yet Vivo customers. It will be offered through an application that will contain medical consultations, wellness programs, discounts at pharmacies, and other benefits. Additional features, new services and partners will be included soon.
This is another step towards building a health and wellness hub around Vivo, aimed at promoting relevant, accessible and quality services, while reinforcing the Company's strategic objective of creating a digital ecosystem, that will increase customer preference and engagement.
The Company will keep its shareholders and the market in general duly informed about the evolution of this partnership, in compliance with the applicable regulations.
São Paulo, May 11, 2021.
David Melcon Sanchez-Friera
CFO and Investor Relations Officer
Telefônica Brasil - Investor Relations
Phone: +55 11 3430 3687
Email: ir.br@telefonica.com
www.telefonica.com.br/ri
Attachments
- Original document
- Permalink
Disclaimer
Telefônica Brasil SA published this content on 12 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 May 2021 17:36:08 UTC.